<DOC>
	<DOCNO>NCT02260089</DOCNO>
	<brief_summary>To evaluate efficacy tolerability telmisartan , give day patient mild moderate hypertension , well ass 24-hour blood pressure profile ABPM</brief_summary>
	<brief_title>Telmisartan Mild Moderate Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients blood pressure level 140/90 mm Hg high ( confirm 2 consecutive visit ) , 18 year old old , regardless sex Suspected known diagnosis arterial hypertension secondary cause Women use effective method contraception , pregnant , breastfeed Systolic blood pressure &gt; 200 mm Hg diastolic blood pressure &gt; 115 mm Hg Laboratory test value two fold upper normal limit Previous intolerance angiotensin conversion enzyme inhibitor angiotensin II blocker ( AIIAR ) New York Heart Association class III IV heart failure History stroke 6 month prior entry study Uncontrolled type 2 diabetes mellitus , define fast glucose level &gt; 140 mg/dL 3 consecutive assessment Patients include another investigational drug study past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>